Area of research
Cardiology and Cardiovascular Medicine · Biomedical Engineering
Research interest
Research interests include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Mechanical Circulatory Support Devices, and Cardiac pacing and defibrillation studies.
Clinical Management and Therapeutic Optimization of Patients with Heart Failure with Reduced Ejection Fraction and Low Blood Pressure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC
How to Handle Polypharmacy in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC
Heart Failure and Obesity: Translational Approaches and Therapeutic Perspectives. A Scientific Statement of the Heart Failure Association of the ESC
The Use of Left Ventricular Ejection Fraction in the Diagnosis and Management of Heart Failure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS)
Implementation of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction (OpTIMa-HF Registry)
Pathophysiology and Clinical Use of Agents with Vasodilator Properties in Acute Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
The Crosstalk Between Immune Activation and Metabolism in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC
Heart Failure with Preserved Ejection Fraction in Cancer Patients and Survivors. A Scientific Statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology
The European Heart Failure Management Resources, Treatment Reimbursement and Activities of Professional and Patient Organizations
Registries on Transcatheter Edge-To-Edge Repair in Heart Failure: Current Evidence and Future Perspectives
Heart failure with reduced ejection fraction and ventricular secondary mitral regurgitation: a holistic approach
Clinical Profiles and Prognostic Impact of Residual Intravascular and Tissue Congestion in Acute Heart Failure
<i>European Journal of Heart Failure</i> Consensus Statement. Heart Failure Pharmacotherapy for Patients with Heart Failure with Reduced Ejection Fraction and Concomitant Atrial Fibrillation: Review of Evidence and Call to Action
Phenotypic clustering analysis of patients rejected for mitral valve interventions: implications for future transcatheter technologies
Heart Failure-Attributed Mortality in Europe, 2012–2021
How to Tackle Therapeutic Inertia in Heart Failure with Reduced Ejection Fraction. A Scientific Statement of the Heart Failure Association of the ESC
Right Heart Failure with Left Ventricular Assist Devices: Preoperative, Perioperative and Postoperative Management Strategies. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC
Differences in Presentation, Diagnosis and Management of Heart Failure in Women. A Scientific Statement of the Heart Failure Association of the ESC
State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases
Tailoring Medical Therapy for Heart Failure with Preserved Ejection Fraction
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC)
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Transcatheter Mitral Valve Replacement or Repair for Secondary Mitral Regurgitation: A Propensity Score-Matched Analysis
Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis
Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score–Matched Comparison
Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis